) or, if accepted, how frequently it will be used. The methods that we currently recommend and any methods we recommend in the future may never gain broad market acceptance. Demonstrated HRT health risks or side effects, as well as negative publicity relating to the same, could negatively impact the perception of patient benefit and generate resistance and opposition from practitioners, which could limit adoption of the Biote Method and have a material adverse impact on our business. To date, a ...
Q2 FY2026 — expected 2026-08-05
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-13 | 2025-12-31 | 0001193125-26-106099 | EDGAR | 89K words |
| 2025-03-14 | 2024-12-31 | 0000950170-25-039394 | EDGAR | — |
| 2024-03-15 | 2023-12-31 | 0000950170-24-032101 | EDGAR | — |
| 2023-03-29 | 2022-12-31 | 0000950170-23-010664 | EDGAR | — |
| 2022-04-07 | 2021-12-31 | 0001193125-22-097864 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-07 | 2025-09-30 | 0001193125-25-272294 | EDGAR | 35K words |
| 2025-08-08 | 2025-06-30 | 0000950170-25-105800 | EDGAR | — |
| 2025-05-09 | 2025-03-31 | 0000950170-25-068059 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125678 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0000950170-24-094529 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0000950170-24-057713 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0000950170-23-063027 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0000950170-23-041796 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0000950170-23-021642 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0000950170-22-024970 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0000950170-22-017446 | EDGAR | — |
| 2022-05-23 | 2022-03-31 | 0001193125-22-156540 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-03 | 0001193125-26-142147 | EDGAR | 3K words |
| 2026-03-11 | 0001193125-26-102129 | EDGAR | — |
| 2026-01-26 | 0001193125-26-022818 | EDGAR | — |
| 2025-11-05 | 0001193125-25-266910 | EDGAR | — |
| 2025-08-06 | 0000950170-25-104014 | EDGAR | — |
| 2025-06-09 | 0001193125-25-137873 | EDGAR | — |
| 2025-06-05 | 0001193125-25-135341 | EDGAR | — |
| 2025-05-14 | 0001193125-25-119861 | EDGAR | — |
| 2025-05-07 | 0000950170-25-065638 | EDGAR | — |
| 2025-04-24 | 0001193125-25-093531 | EDGAR | — |
99 total filings indexed. 72 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001819253 |
| Ticker | BTMD |
| Exchange | Nasdaq |
| SIC | 2833: Medicinal Chemicals & Botanical Products |
| Website | https://www.biote.com |
| Listed | 2022-05-27 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report